These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23679265)

  • 1. Exploration of molecular mechanisms of diffuse large B-cell lymphoma development using a microarray.
    Zhang ZX; Shen CF; Zou WH; Shou LH; Zhang HY; Jin WJ
    Asian Pac J Cancer Prev; 2013; 14(3):1731-5. PubMed ID: 23679265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of key genes and pathways associated with colorectal cancer with microarray technology.
    Liu YJ; Zhang S; Hou K; Li YT; Liu Z; Ren HL; Luo D; Li SH
    Asian Pac J Cancer Prev; 2013; 14(3):1819-23. PubMed ID: 23679280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of potential key genes associated with diffuse large B-cell lymphoma based on microarray gene expression profiling.
    Luo X; Shi F; Qiu H; Tong Y; Gao X
    Neoplasma; 2017; 64(6):824-833. PubMed ID: 28895406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening of hub genes and pathways in colorectal cancer with microarray technology.
    Wang Y; Zheng T
    Pathol Oncol Res; 2014 Jul; 20(3):611-8. PubMed ID: 24504536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of potential drugs for diffuse large b-cell lymphoma based on bioinformatics and Connectivity Map database.
    Luo B; Gu YY; Wang XD; Chen G; Peng ZG
    Pathol Res Pract; 2018 Nov; 214(11):1854-1867. PubMed ID: 30244948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
    Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
    Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatic validation identifies candidate key genes in diffuse large-B cell lymphoma.
    Huang Q; Liu F; Shen J
    Per Med; 2019 Jul; 16(4):313-323. PubMed ID: 31331250
    [No Abstract]   [Full Text] [Related]  

  • 8. [Identify the Molecular Target of Diffuse Large B Cell Lymphoma by Bioinformatics Analysis].
    Zhou Y; He S
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1585-1591. PubMed ID: 33067958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.
    Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R
    Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein-protein interaction networks and modules analysis for colorectal cancer and serrated adenocarcinoma.
    Yu H; Ye L; Wang J; Jin L; Lv Y; Yu M
    J Cancer Res Ther; 2015; 11(4):846-51. PubMed ID: 26881529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Biomarkers for Early Diagnosis of Acute Myocardial Infarction.
    Ge WH; Lin Y; Li S; Zong X; Ge ZC
    J Cell Biochem; 2018 Jan; 119(1):650-658. PubMed ID: 28636181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinically molecular subtype and prognosis in diffuse large B cell lymphoma.
    Zhou M; Zhao H; Xu W; Bao S; Cheng L; Sun J
    Mol Cancer; 2017 Jan; 16(1):16. PubMed ID: 28103885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis.
    Hu S; Liao Y; Chen L
    Med Sci Monit; 2018 Sep; 24():6438-6448. PubMed ID: 30213925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microarray-based gene expression profiling reveals genes and pathways involved in the oncogenic function of REG3A on pancreatic cancer cells.
    Xu Q; Fu R; Yin G; Liu X; Liu Y; Xiang M
    Gene; 2016 Mar; 578(2):263-73. PubMed ID: 26719042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated analysis of genome‑wide gene expression and DNA methylation microarray of diffuse large B‑cell lymphoma with TET mutations.
    Liu P; Jiang W; Zhao J; Zhang H
    Mol Med Rep; 2017 Oct; 16(4):3777-3782. PubMed ID: 28731140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of key microRNAs associated with diffuse large B-cell lymphoma by analyzing serum microRNA expressions.
    Meng Y; Quan L; Liu A
    Gene; 2018 Feb; 642():205-211. PubMed ID: 29128636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Hub Genes and Pathways Associated with CAR-T Cell-Mediated Neurotoxicity in DLBCL.
    Wang Y; Li B; Wang Z; Li C; Bi G; Liu G; Teng Q; Guo D
    Clin Lab; 2021 Aug; 67(8):. PubMed ID: 34383407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of key genes and pathways associated with classical Hodgkin lymphoma by bioinformatics analysis.
    Kuang Z; Guo L; Li X
    Mol Med Rep; 2017 Oct; 16(4):4685-4693. PubMed ID: 28791394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.